drugset / Trial / NCT05131971
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants
RandomizedSequentialDouble-blindTreatment
Summary
This is a first time in human study designed to assess the safety, tolerability, pharmacokinetics and PD of GSK3888130B over a range of dose levels in healthy participants.
Timeline
- Start
- 2021-11-01
- Primary completion
- 2023-10-12
- Completion
- 2023-10-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK3888130B | Unknown | — | — |